I disagree. EsimatedProphet was a shill's shill: Warning

New Post Public Reply Private Reply Replies (1) Message Board
It takes a brain PaperProphet #11901
I disagree. EsimatedProphet was a shill's shill:

Warning to the JBII Shorts
by estimated_prophet77 . Jan 6, 2010 2:41 PM . Permalink ( When JBII closed at $6.50 )

I'm here to issue you all a warning.

All of you people here are in graaaaaave danger!

99% of the time I would agree with you to short a stock that has run like this. I have played numerous huge runners on the OTC. Some I knew better, and sold at or near their peaks. Some I was stupid, and believed in, and had to sell for small gains when I had huge gains, and one I broke even on.

I can tell you emphatically, that this is the 1 out of 100 that is actually real. We know that a typical P&D peaks out around 5-6. JBII went to 7.70! Most scams can't break the $5 mark, or at least not for very long. You would expect to see JBII fall below $5 within 30 days, if it is a P&D. You know that it may retest the highs, but that it will then turnover and be lights out. So, I know you are biting your nails here as you wait this out.

I would imagine that 90% of you are underwater at todays 6.30 high that is just printing. If we hold 6, you are in a world of hurt. Your best cover is going to be in the 4.80-5.15 range. I doubt you get that, but maybe. I would like to think, since I know this is a real company, that you don't get that sweet spot cover that allows 50% or more of you shorts to cover even or with a slight gain.

I have never been so confident that a company is real in my life. I speak with very astute traders from all different aspects, and decades of experience in the professional investing field. We all agree this is the greatest stock opportunity we have ever seen. We have a true out of the box CEO here. This is truly a classic story that will be all over the media in the coming year. John solves a huge problem by building the hardware and software to convert legacy data. This is so big, that MIT and NASA sole sourced him. Think about it, you are the only man in the world that can read DECADES of KNOWLEDGE stored on tapes that can't be read. Remember how people were acting around the tech boom? The future is today, tomorrow is now, we are all going to be driving rocket ships, and talking with our minds!!!!!!!!! So, John Bordynuik keeps his mouth shut, and goes around amassing all this knowledge form any institution or corporation willing to part with all these old tapes just taking up space. Knowledge is power, and John just ignited a SUPERNOVA!

The CEO converts 10/10 on his goals. The pattern is very clear. As it becomes more clear for the skeptics, you'll be covering or joining in at much higher prices. Let me tell you, the word is getting around in BIG CIRCLES that we have the next Google before our eyes.

I'm warning you, cover in the price points I listed, or just do it now, or else be prepared to close that account you are shorting in, and regroup when you have money to join the party again.

http://finance.yahoo.com/mbview/threadview/?m...&frt=1

Plastic2Oil, Inc. (PTOI) Stock Research Links

PTOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 6

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 5

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading

Top 5 Most Recently Viewed Articles

Sisecam Revolutionizes Whisky Packaging with Lightweight Design

Updated Category News Views 98

Sisecam pulled a rabbit out of the hat with its new glass whisky bottle, specifically for Johnnie Walker Blue Label Ultra. This wasn’t just any bottle; it weighed in at a feather-light 180 grams—an astonishing 80% reduction from traditional models. Traders were buzzing when they heard about this during the London Design Festival unveiling, eyeing how such innovation...

Continue Reading
Kelun-Biotech Expands Sacituzumab Tirumotecan Use in Lung Cancer

Updated Category News Views 263

Kelun-Biotech’s Innovative Therapy Gains Approval CHENGDU, China – Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. proudly announces the recent approval of its groundbreaking therapy, sacituzumab tirumotecan (sac-TMT), designed to target specific forms of lung cancer. This approval signifies the third indication for sac-TMT in treating adult patients with epidermal...

Continue Reading
Intel's Smart Moves Propel Stock Recovery: What's Next?

Updated Category News Views 95

Intel's Resurgence in the Tech Landscape Intel Corporation, once thought to be sidelined, entered the year with renewed vigor. Once seen as losing ground in the AI chip domain, the company has managed to reclaim its space through clever partnerships and a decisive reshuffle in leadership. By the start of 2026, the price per share hovered around $41.90, indicating a...

Continue Reading
Five Below Faces Securities Fraud Lawsuit: Know Your Rights

Updated Category News Views 60

Five Below Faces Serious Legal Challenges Five Below, Inc. is currently dealing with significant legal issues following a lawsuit that has been filed against the company and several of its top executives. Investors who put their trust in Five Below are understandably worried about the status of their investments and the company's overall integrity. Details of the Lawsuit...

Continue Reading
Why CrowdStrike's Potential Growth Makes It a Top Buy Right Now

Updated Category News Views 239

Insights into CrowdStrike’s Ongoing Growth Potential CrowdStrike (NASDAQ: CRWD) shows no signs of slowing down, and its growth trajectory in the cybersecurity sector is promising. This year has started with challenges, such as a decline in stock prices driven by lower-than-expected earnings guidance. However, this dip presents a unique opportunity for potential...

Continue Reading